Selective small-molecule inhibition of an RNA structural element
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ribocil binding inhibits translation of ribB transcript in E. coli, inducing cell death by riboflavin starvation.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“a high throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, called “ribocil”, that targets a regulatory non-coding region (i.e. riboswitch) in the mRNA of a synthase involved in the pathway, ribB [123].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“ribocil administration, although only at high concentrations, significantly reduced bacterial burden in a mouse model of systemic infection with E. coli”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Self-citationBad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Research works printed but not linked: 2
- Kodali, S. et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem. 280, 1669–1677 (2005) · DOI
- Bricogne, G. et al. BUSTER version 2.11.5 http://www.globalphasing.com (2014)
Cited by
Items 301–400 of 406
Srivastava, Y., Akinyemi, O., Rohe, T. C., Pritchett, E. M., Baker, C. D., Sharma, A., Jenkins, J. L., Mathews, D. H., & Wedekind, J. E. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae886 · Cited by 4
Characterization of the glmS Ribozymes from Listeria Monocytogenes and Clostridium Difficile
Esser, A., & Mayer, G. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202202376 · Cited by 5
Automation in the hematology laboratory.
Ja, D. L., Rutten, W. P. F., Schmidt, N. A., Jg, E., & Jj, V. (1976) · PubMed · Cited by 4
Prospects for Riboswitches in Drug Development
Mohsen, M. G., & Breaker, R. R. (2024) · Methods and principles in medicinal chemistry · doi:10.1002/9783527840458.ch8 · Cited by 5
Emergence of antibiotic resistance in gut microbiota and its effect on human health
Kumar, M., Sharma, A., Verma, A., & Shrivastava, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00002-7 · Cited by 4
Opportunities for Riboswitch Inhibition by Targeting Co-Transcriptional RNA Folding Events
Stephen, C. N., Palmer, D., & Mishanina, T. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910495 · Cited by 3
“However, ribocil-resistant E. coli mutants have been identified, and importantly, all mutations conferring resistance mapped to the riboswitch aptamer domain or expression platform [40,41].”
BackgroundHübenthal, A., Panchal, V. N., Brenk, R., & Mack, M. (2025) · Journal of Bacteriology · doi:10.1128/jb.00308-25 · Cited by 3
“…screening program that led to the identification of ribocil, which targets FMN riboswitches of a variety of bacte ria, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis, and reduces downstream gene expression of riboflavin biosynthesis and transport genes (46, 47).”
Oketade, N., Chengalroyen, M. D., Kain, D. C., Lewinsohn, D. M., & Dobos, K. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656167 · Cited by 3
Singh, R. N., & Sani, R. K. (2024) · Microorganisms · doi:10.3390/microorganisms12050960 · Cited by 3
“The selective inhibition of the FMN riboswitch inhibits growth in E. coli [72].”
BackgroundAn Orphan Riboswitch Unveils Guanidine Regulation in Bacteria
Mok, W. W. K., & Brynildsen, M. P. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.001 · Cited by 3
“In addition, a riboswitch has been identified as the molecular target of a novel antimicrobial (Howe et al., 2015), which suggests that these RNA-based regulators could provide an additional source of antibiotic targets.”
BackgroundSimilarities and Differences in Ligand Binding to Protein and RNA Targets: The Case of Riboflavin
Bosio, S., Bernetti, M., Rocchia, W., & Masetti, M. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00420 · Cited by 6
Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_12 · Cited by 3
Targeting RNA with Small Molecules
Zhang, P., Bush, J. A., Childs‐Disney, J. L., & Disney, M. D. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_96 · Cited by 3
Sensing diclofenac with DNA aptamers: an atomistic picture from molecular modelling
Bonnant, L., Bonardi, A., Ottochian, A., Mamadou, A., Njogu, R. E. N., Slim, C., Griveau, S., Labat, F., Ciofini, I., & Turelli, M. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp01353d · Cited by 2
Specific targeting of transcriptional T-box riboswitches leads to effective inhibition of S. aureus
Γιαρίμογλου, Ν., Kouvela, A., Papakyriakou, A., Zhang, J., Stamatopoulou, V., & Stathopoulos, C. (2025) · RNA · doi:10.1261/rna.080644.125 · Cited by 2
X-Ray Crystallography to Study Conformational Changes in a TPP Riboswitch
Nuthanakanti, A., Ariza‐Mateos, A., & Serganov, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2687-0_14 · Cited by 2
Jara, B. B., & Hammond, M. C. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_91-1 · Cited by 3
Crystallographic analysis of G-clamp–RNA complex assisted by large scale RNA-binding profile
Nagasawa, R., Onizuka, K., Kawamura, K., Tsuzuki, K., Murase, H., Komatsu, K. R., Miyashita, E., Saito, H., Kondo, J., & Nagatsugi, F. (2024) · Chemical Communications · doi:10.1039/d4cc04677c · Cited by 2
Riboswitch Dynamics and Their Expanding Biotechnological Applications
Chen, D., & Liu, Y. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100027 · Cited by 2
Jahangirnejad, S., Côté, J., & Lafontaine, D. A. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169207 · Cited by 2
Vrentas, C. E., Adler, J. J., Kleinschmit, A. J., & Sewall, J. M. (2018) · Journal of Microbiology and Biology Education · doi:10.1128/jmbe.v19i2.1501 · Cited by 2
Furuzono, T., Murata, A., Okuda, S., Mizutani, K., Adachi, T., & Nakatani, K. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116070 · Cited by 3
An Evolutionary Trace method defines functionally important bases and sites common to RNA families
Novikov, I. B., Wilkins, A. D., & Lichtarge, O. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007583 · Cited by 2
“Indeed, a number of inhibitors have already been developed to target pathogenic fncRNA, including riboswitches [10] and the ribosome [11].”
BackgroundRNA Ensembles from Solvent Accessibility Data: Application to the SAM-I Riboswitch Aptamer Domain
Xie, J., & Frank, A. T. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c11503 · Cited by 2
Jones, L. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc256 · Cited by 2
“X-ray structure of ribocil (spacefill) bound in the FMN riboswitch (PDB code 5KX9, viewed in NGL) [154].”
BackgroundMechanistic Studies of Small Molecule Ligands Selective to RNA Single G BulgesPreprint
Hegde, S., Akhter, S., Tang, Z., Qi, C., Yu, C., Lewicka, A., Liu, Y., Koirala, K., Reibarkh, M., Battaile, K. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.14.618236 · Cited by 2
Chen, P., Liu, X., & Tan, L. (2023) · Polyhedron · doi:10.1016/j.poly.2023.116460 · Cited by 1
Interaction between a fluoroquinolone derivative KG022 and RNAs: effect of the bulged residues
Ichijo, R., & Kawai, G. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf039 · Cited by 1
Pascali, M. C. D., Dreymann, N., Menger, M., Rant, U., & Engelen, W. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100840 · Cited by 1
Zhang, X., Liu, X., 毛希安, Xu, C., He, Y., Deng, H., Yang, Q., Xiong, Y., & Ren, J. (2026) · Food Microbiology · doi:10.1016/j.fm.2026.105276 · Cited by 1
Wykes, H., Le, V. V. H., & Rakonjac, J. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001356 · Cited by 1
“…secondary structural model of the flavin mononucleotide (FMN) aptamer at the 5 ′ -untranslated region of the ribB mRNA (corresponding to the reverse strand at the coordinates 3177808–3178077 of the reference E. coli BW25113 genome) was extracted from [21] and visualized using Varne v3.”
Higo, J., Kasahara, K., Sakuraba, S., Bekker, G., Kamiya, N., Fukuda, I., Takahashi, T., & Fukunishi, Y. (2025) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v22.0011 · Cited by 1
Schwendenmann, N., Burger, S., Steiner, L., Seufert, L., Kohl, M., Mack, M., & Egert, M. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01317-w · Cited by 3
Hedwig, V., Spöring, M., Aspnes, G. E., Gottschling, D., Klein, H., Klugmann, M., Kreuz, S., Ries, B., Schnapp, G., Scharsich, S., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.5c00739 · Cited by 1
Ramireddy, R. R., Shortridge, M. D., Vidalala, V., Chaubey, B., Tang, C., Olsen, G. L., & Varani, G. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag186 · Cited by 2
“While riboswitches, aptamers, and ribozymes demonstrate that complex RNAs recognize small molecules specifically [ 13 , 15 ], these structures are rare in eukaryotic mRNAs and ncRNAs.”
Yousuf, S., Misba, M., & Bhat, S. Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1852766 · Cited by 2
“…they arise naturally under physiological conditions driven by sequence composition, DNA supercoiling, transcriptional activity, ionic environment, and interactions with proteins and small molecules (Rawal et al., 2006; Kouzine and Levens, 2007; Howe et al., 2015; Hänsel-Hertsch et al., 2016).”
Gupta, S., Gupta, S., Kumar, P., Maini, J., & Bharadwaj, M. (2019) · Journal of Cancer Genetics and Biomarkers · doi:10.14302/issn.2572-3030.jcgb-19-2973 · Cited by 1
Chemical Tools to Target Noncoding RNAs
Bonnet, M., & Duca, M. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_36 · Cited by 1
Wan, K., Tan, Z., & Tan, L. (2025) · Inorganica Chimica Acta · doi:10.1016/j.ica.2025.122556 · Cited by 1
Antunes, D., Santos, L. H., Caffarena, E. R., & Guimarães, A. C. R. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2530092 · Cited by 1
“For instance, Howe et al. (2015) demonstrated the selective inhibition of a bacterial ribozyme using a small molecule that mimics the natural ligand.”
Aptamer and Riboswitches: A Novel Tool for the Need of New Antimicrobial Active Compounds
Díaz-García, V. M., & Retamal-Morales, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820054-4.00013-6 · Cited by 1
Bogaty świat ryboprzełączników
Machtel, P. (2020) · Postępy Biochemii · doi:10.18388/pb.2020_331 · Cited by 1
Rode, A. B., Endoh, T., & Sugimoto, N. (2018) · Angewandte Chemie · doi:10.1002/ange.201803052 · Cited by 1
Chemical Tools to Target Noncoding RNAs
Bonnet, M., & Duca, M. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_36-1 · Cited by 1
Jara, B. B., & Hammond, M. C. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_91 · Cited by 1
RNA: Opening New Doors in Medicinal Chemistry
Garner, A. L., & Djurić, S. W. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00421 · Cited by 1
AI-Generated Virtual Libraries Could Help Uncover RNA-Specific Regions of Chemical SpacePreprint
Xu, Z., & Frank, A. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.05.479230 · Cited by 1
“6 Further, the identification of antifungal molecules (by Pyle and coworkers) that target the highly structured group II intron and inhibit splicing, 7 along with other recent discoveries, 8–12 provides additional validation of the viability of RNAs, particularly highly structured RNAs, as drug…”
BackgroundDrugPred_RNA – Structure-Based Druggability Predictions for RNA Binding SitesPreprint
Rekand, I. H., & Brenk, R. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13303187.v1 · Cited by 1
Thakare, R., Taghavi, A., Wang, J., Childs‐Disney, J. L., Li, C., Disney, M. D., & Li, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.18.732920 · Cited by 5
Sheppard, T. L. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1973
Polaski, J. T. (2016) · CU Scholar (University of Colorado Boulder)
Holbrook‐Smith, D. (2016) · TSpace (University of Toronto) · Cited by 1
Ortega, F. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.031
Augmented base pairing networks encode RNA-small molecule binding preferencesPreprint
Oliver, C., Mallet, V., Gendron, R. S., Reinharz, V., Hamilton, W. L., Moitessier, N., & Waldispühl, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/701326
“Among them, Ribocil, which has recently been uncovered through a phenotypic assay to target the FMN riboswitch is currently undergoing clinical trials as a novel antibiotic [17].”
BackgroundWakchaure, P. D., & Ganguly, B. (2019) · Croatica Chemica Acta · doi:10.5562/cca3550
Tumorigenesis-Related Long Noncoding RNAs and Their Targeting as Therapeutic Approach in Cancer
Aprile, M., Călin, G. A., Cimmino, A., & Costa, V. (2020) · RNA technologies · doi:10.1007/978-3-030-44743-4_11
Chemical Probes to Control RNA Function
François‐Moutal, L., Miranda, V. G., Sandino, M., & Khanna, M. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00214
Discovery of Novel Antibiotics via Streptomyces sporulation
McAuley, S. (2019) · TSpace (University of Toronto) · Cited by 1
Golabi, F., Aghdam, E. M., Shamsi, M., Sedaaghi, M. H., Barzegar, A., & Hejazi, M. S. (2020) · Bioimpacts · doi:10.34172/bi.2021.17
Sugimoto, N. (2021) · Wiley eBooks · doi:10.1002/9783527817856.ch13
Dep Of Chemistry, U. N. S. (2019) · Proceeding of Chemistry Conferences · doi:10.20961/pcc.v3i0.27520
DrugPred_RNA – Structure-Based Druggability Predictions for RNA Binding SitesPreprint
Rekand, I. H., & Brenk, R. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13303187
Faculty Opinions recommendation of Frameworks for targeting RNA with small molecules.
Lowe, J. A., III (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739239138.793581334
Chingarande, G. R. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/90988
Metabolization of α-D-carba-glucosamine in vivo generates antimetabolites of cell wall precursorsPreprint
Mund, M., Friz, S., Esser, A., Matzner, D., Babczyk, A., Menche, D., Brötz‐Oesterhelt, H., Mayer, C., & Mayer, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.08.527593
Targeting RNA with Small Molecules
Zhang, P., Bush, J. A., Childs‐Disney, J. L., & Disney, M. D. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_96-1
Structured RNAs and Their Role in Biology and Therapeutics
Fedeles, B. I., & Singh, V. (2023) · RNA technologies · doi:10.1007/978-3-031-36390-0_5
Tidwell, E. D., Kilde, I. R., Leskaj, S., & Koutmos, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020735
“Although other groups have used this property to monitor the competition of FMN with ligands [16,38], the method has not been optimized as a primary high-throughput screening method.”
BackgroundMethodInfluentialRNA folding and structure prediction
Li, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95917-9.00011-0
Recent advances in RNA cryo-EM structure determination
Pan, Z., Jia, X., & Su, Z. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0286
From Ligand‐Binding Aptamers to Molecular Switches
Li, S., Zhang, X., Luo, T., Liu, X., Zhai, T., & Gu, H. (2024) · Wiley eBooks · doi:10.1002/9783527840816.ch3
Stille, J. K., Takyi, N. A., Ayon, O. S., Rivera, M., Satkunarajah, T., Pottel, J., Mittermaier, A., McKeague, M., & Moitessier, N. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-x6n6s
Chemical Matter That Binds RNA
Swanson, E. G., Cai, Z., & Hargrove, A. E. (2024) · Methods and principles in medicinal chemistry · doi:10.1002/9783527840458.ch5
High‐Resolution Structures of RNA
Braun, L., Alirezaeizanjani, Z., Tesch, R., & Kooshapur, H. (2024) · Methods and principles in medicinal chemistry · doi:10.1002/9783527840458.ch3 · Cited by 1
Li, J., Hong, X., Chen, Y., Bin, Y., Yang, H., Shi, C., Zeng, X., Zhang, D., Guo, Z., & Zhang, X. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00175
Off‐Target Screening Strategies
Roberts, S., & Lightfoot, H. L. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch4
Garner, A. L., Bonnet, M., Carozza, C. A., Eby, O. G., & Dean, M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00015-7
Korn, R., Anthony, J. S., Furumo, Q., Gray, E. C., Warrier, I., & Meyer, M. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.649428
“The antibiotic ribocil-C has been shown to interact directly with FMN riboswitches 25,26 .”
Fullenkamp, C. R., Mehdi, S., Jones, C. P., Tenney, L., Pichling, P., Prestwood, P. R., Ferré-D’Amaré, A. R., Tiwary, P., & Schneekloth, J. S. (2025) · Angewandte Chemie · doi:10.1002/ange.202505971 · Cited by 1
Väre, V. Y. P. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/gg69-d28c
Structural Characterization of Biotherapeutics and New Modalities
Lello, P. D., & Lupardus, P. J. (2025) · Wiley eBooks · doi:10.1002/9781394236145.ch7 · Cited by 1
Chen, Q., Fujiwara, A., Nakatani, K., Kawai, G., & Murata, A. (2025) · Chemical Science · doi:10.1039/d5sc05255f · Cited by 2
Discovery of RNA-binding fragments using biolayer interferometry
Panchal, V. N., Husmann, J.-Å., Günther, K., Zeeshan, M., Haug, B. E., & Brenk, R. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00673b
“1), a flavin mononucleotide (FMN) riboswitch targeting antibiotic, demonstrated that riboswitches can bind ligands with distinct chemical scaffolds, 38 setting precedence for designing selective drug-like molecules which are less likely to interfere with host metabolism.”
Harnessing AI for nucleic acid drug discovery: Small molecule targeting DNA and RNA
Chen, Q., & Nakatani, K. (2025) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2025.10.001 · Cited by 1
Importance of Riboswitch-regulated Genes for Pseudomonas aeruginosa
Jahangirnejad, S., Côté, J., & Lafontaine, D. A. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169724
Structural similarities of molecules selectively binding the prfA thermosensor RNAPreprint
Scheller, D., Das, R., Chorell, E., & Johansson, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.11.711090
Clairoux, A., Rivera, M., McKeague, M., & Mittermaier, A. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104439
Méthodes de synthèse de ligands et sondes chimiques d'ARN
Fleurisson, C. (2023) · theses.fr (ABES) · doi:10.70675/9501ea44ze354z4e26zb92bzcd007e6cf9c9
Ciblage d'ARN non codants oncogéniques par des petites molécules de synthèse
Pernak, M. (2023) · theses.fr (ABES) · doi:10.70675/f86abd5cz1e80z4ac3z8b7ez6eb76d625a54 · Cited by 1
Advanced computational techniques to aid the rational design of small molecules targeting RNA
Panei, F. P. (2024) · theses.fr (ABES) · doi:10.70675/f278a628z9cf1z4408za15fzfed05518864e
Development of synthetic RNA using ultrahigh-throughput microfluidic screening
Husser, C. (2024) · theses.fr (ABES) · doi:10.70675/cc16e607z6679z4d14za678z981e7ce8fd8a
Structure-based discovery of small molecules that allosterically modulate RNA functionPreprint
Su, Z., Pan, Z., Wu, H., Hu, H., Zou, J., Ma, H., Ni, H., Wang, L., Zhao, J., Sun, X., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9338412/v1
Design and Applications of Riboswitches
Kadu, R. P., Shinde, K., & Rode, A. B. (2026) · Springer eBooks · doi:10.1007/978-981-95-3957-4_9
Wang, Z., Labuhn, H., Moulinas, R., Salthouse, D. G., Nakamura, A., Akahori, Y., Kon, A., Kawasaki, S., Feri, A., & Beurdeley, P. (2026) · RNA Biology · doi:10.1080/15476286.2026.2705059
“Small molecules mimicking the active riboswitch ligand have been developed to inhibit bacterial growth, such as Ribocil for the flavin mononucleotide (FMN) riboswitch [6,7].”
Traykovska, M., Pavlova, N., Kaloudas, D., & Robert Penchovsky, D. R. N. (2026) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2026.107700
HARIBOSS++: An Integrated Platform for RNA-Targeted Drug DesignPreprint
Marengo, M., Chapeaublanc, E., Ménager, H., Gkeka, P., & Bonomi, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.07.749797
“…RNA-targeting SMs have been developed, including Linezolid (Zyvox) in the early-mid 1990s 11 , which binds to ribosomal RNA to inhibit bacterial translation, and Ribocil from Merck in 2015 12 , which targets a flavin mononucleotide riboswitch to regulate gene expression at the translational level.”
The rapid emergence of small molecule RNA modulator hit discovery: unlocking the potential
Moore, R., Bonetti, A., Cox, R. J., Geschwindner, S., Giurrandino, M., Cuesta, S. M., & Schießer, S. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2736534
Metadata
- Authors
- Howe, J. A., Wang, H., Fischmann, T. O., Balibar, C. J., Xiao, L., Galgoci, A. M., Malinverni, J. C., Mayhood, T., Villafania, A., Nahvi, A., Murgolo, N., Barbieri, C. M., Mann, P. A., Carr, D., Xia, E., Zuck, P., Riley, D., Painter, R. E., Walker, S. S., Sherborne, B., de Jesus, R., Pan, W., Plotkin, M. A., Wu, J., Rindgen, D., Cummings, J., Garlisi, C. G., Zhang, R., Sheth, P. R., Gill, C. J., Tang, H., & Roemer, T.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Roemer, Terry
- ORCID
- Venue
- Nature
- Published
- 2015-09-30
- Volume
- 526
- Issue
- 7575
- Pages
- 672-677
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1931081986
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 43 · 2023: 34 · 2022: 38 · 2021: 35 · 2020: 39 · 2019: 43 · 2018: 42 · 2017: 40 · 2016: 35 · 2015: 2
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Institute of Microbiology, Chinese Academy of Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- riboswitches, flavin mononucleotide, non-coding RNA, riboflavin biosynthesis, antibiotic discovery, phenotypic screening
- MeSH terms
- Animals, Bacteria, Base Sequence, Escherichia coli Infections, Female, Flavin Mononucleotide, Heat-Shock Proteins, Ligands, Mice, Inbred DBA, Models, Molecular, Molecular Sequence Data, Pyrimidines, Riboflavin, RNA, Bacterial, Substrate Specificity, Reproducibility of Results, Gene Expression Regulation, Bacterial, Crystallography, X-Ray, Intramolecular Transferases, Escherichia coli Proteins, Mice, Aptamers, Nucleotide, Riboswitch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.